Biomarkers for Predicting Response to HER2-targeted TherapiesPei Rong Evelyn LeeeScholarship (California Digital Library)January 1, 2018Cited by 0SaveCiteExport RISWatch citationsRelated PapersRedefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies|Cancer Cell|2022|335Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors|Breast Cancer Research|2017|24Abstract P6-11-02: Spatial distribution of veliparib measured by matrix assisted laser desorption ionization mass spectrometry in triple negative breast cancer tumors|Cancer Research|2015|0